Literature DB >> 28993291

PAK4 crystal structures suggest unusual kinase conformational movements.

Eric Y Zhang1, Byung Hak Ha1, Titus J Boggon2.   

Abstract

In order for protein kinases to exchange nucleotide they must open and close their catalytic cleft. These motions are associated with rotations of the N-lobe, predominantly around the 'hinge region'. We conducted an analysis of 28 crystal structures of the serine-threonine kinase, p21-activated kinase 4 (PAK4), including three newly determined structures in complex with staurosporine, FRAX486, and fasudil (HA-1077). We find an unusual motion between the N-lobe and C-lobe of PAK4 that manifests as a partial unwinding of helix αC. Principal component analysis of the crystal structures rationalizes these movements into three major states, and analysis of the kinase hydrophobic spines indicates concerted movements that create an accessible back pocket cavity. The conformational changes that we observe for PAK4 differ from previous descriptions of kinase motions, and although we observe these differences in crystal structures there is the possibility that the movements observed may suggest a diversity of kinase conformational changes associated with regulation. AUTHOR
SUMMARY: Protein kinases are key signaling proteins, and are important drug targets, therefore understanding their regulation is important for both basic research and clinical points of view. In this study, we observe unusual conformational 'hinging' for protein kinases. Hinging, the opening and closing of the kinase sub-domains to allow nucleotide binding and release, is critical for proper kinase regulation and for targeted drug discovery. We determine new crystal structures of PAK4, an important Rho-effector kinase, and conduct analyses of these and previously determined structures. We find that PAK4 crystal structures can be classified into specific conformational groups, and that these groups are associated with previously unobserved hinging motions and an unusual conformation for the kinase hydrophobic core. Our findings therefore indicate that there may be a diversity of kinase hinging motions, and that these may indicate different mechanisms of regulation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Back pocket; Crystal structure; Gatekeeper; Inhibitor design; Kinase conformation; Protein structure

Mesh:

Substances:

Year:  2017        PMID: 28993291      PMCID: PMC5742302          DOI: 10.1016/j.bbapap.2017.10.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  61 in total

1.  600 ps molecular dynamics reveals stable substructures and flexible hinge points in cAMP dependent protein kinase.

Authors:  I Tsigelny; J P Greenberg; S Cox; W L Nichols; S S Taylor; L F Ten Eyck
Journal:  Biopolymers       Date:  1999-10-15       Impact factor: 2.505

2.  Understanding protein flexibility through dimensionality reduction.

Authors:  Miguel L Teodoro; George N Phillips; Lydia E Kavraki
Journal:  J Comput Biol       Date:  2003       Impact factor: 1.479

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

Review 4.  PKA: a portrait of protein kinase dynamics.

Authors:  S S Taylor; J Yang; J Wu; N M Haste; E Radzio-Andzelm; G Anand
Journal:  Biochim Biophys Acta       Date:  2004-03-11

5.  Structural analysis of protein kinase A mutants with Rho-kinase inhibitor specificity.

Authors:  Stefan Bonn; Saturnino Herrero; Christine B Breitenlechner; Andrea Erlbruch; Wolf Lehmann; Richard A Engh; Michael Gassel; Dirk Bossemeyer
Journal:  J Biol Chem       Date:  2006-05-12       Impact factor: 5.157

6.  Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil.

Authors:  Hiroto Yamaguchi; Miyuki Kasa; Mutsuki Amano; Kozo Kaibuchi; Toshio Hakoshima
Journal:  Structure       Date:  2006-03       Impact factor: 5.006

7.  Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain.

Authors:  Akhilesh Pandey; Ippeita Dan; Troels Z Kristiansen; Norinobu M Watanabe; Jesper Voldby; Eriko Kajikawa; Roya Khosravi-Far; Blagoy Blagoev; Matthias Mann
Journal:  Oncogene       Date:  2002-05-30       Impact factor: 9.867

8.  The structure of dimeric ROCK I reveals the mechanism for ligand selectivity.

Authors:  Marc Jacobs; Koto Hayakawa; Lora Swenson; Steven Bellon; Mark Fleming; Paul Taslimi; John Doran
Journal:  J Biol Chem       Date:  2005-10-24       Impact factor: 5.157

9.  Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity.

Authors:  Christine Breitenlechner; Michael Gassel; Hiroyoshi Hidaka; Volker Kinzel; Robert Huber; Richard A Engh; Dirk Bossemeyer
Journal:  Structure       Date:  2003-12       Impact factor: 5.006

10.  MUSCLE: a multiple sequence alignment method with reduced time and space complexity.

Authors:  Robert C Edgar
Journal:  BMC Bioinformatics       Date:  2004-08-19       Impact factor: 3.169

View more
  4 in total

1.  Recognition of physiological phosphorylation sites by p21-activated kinase 4.

Authors:  Ashwin K Chetty; Joel A Sexton; Byung Hak Ha; Benjamin E Turk; Titus J Boggon
Journal:  J Struct Biol       Date:  2020-06-23       Impact factor: 2.867

2.  Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis.

Authors:  Fiona J Sorrell; Lena Marie Kilian; Jonathan M Elkins
Journal:  Biochem J       Date:  2019-04-04       Impact factor: 3.857

3.  Targeting p21-activated kinase 4 (PAK4) with pyrazolo[3,4-d]pyrimidine derivative SPA7012 attenuates hepatic ischaemia-reperfusion injury in mice.

Authors:  Yuancheng Mao; Eun Lee; Xiaohui Yang; Eun Ju Bae; Raok Jeon; Byung-Hyun Park
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 4.  Progress in the therapeutic inhibition of Cdc42 signalling.

Authors:  Natasha P Murphy; Helen R Mott; Darerca Owen
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.